Katalog der Deutschen Nationalbibliothek

Ergebnis der Suche nach: Placebo
im Bestand: Gesamter Bestand

9771 - 9780 von 9887

	9771	Weniger Rekurrenz bei Hochrisikopatienten Enthalten in Gastronews Bd. 6, 16.2.2019, Nr. 1, date:2.2019: 65
	9772	Wenn die Beine nicht mehr wollen Enthalten in Info Neurologie & Psychiatrie Bd. 17, 25.2.2015, Nr. 2, date:2.2015: 63
	9773	Wettrennen der CGRP-gerichteten Migräne-Therapien Enthalten in Psychopraxis. Neuropraxis Bd. 21, 1.6.2018, Nr. 3, date:6.2018: 94-96
	9774	What is the effect of spinal manipulation on the pressure pain threshold in young, asymptomatic subjects? A randomized placebo-controlled trial, with a cross-over design Enthalten in Chiropractic & manual therapies Bd. 28, 7.2.2020, Nr. 1, date:12.2020: 1-10
	9775	What is the ideal dose and power output of low-level laser therapy (810 nm) on muscle performance and post-exercise recovery? Study protocol for a double-blind, randomized, placebo-controlled trial Enthalten in Trials Bd. 15, 27.2.2014, Nr. 1, date:12.2014: 1-7
	9776	What is the optimal time-response window for the use of photobiomodulation therapy combined with static magnetic field (PBMT-sMF) for the improvement of exercise performance and recovery, and for how long the effects last? A randomized, triple-blinded, placebo-controlled trial Enthalten in BMC sports science, medicine & rehabilitation Bd. 12, 19.10.2020, Nr. 1, date:12.2020: 1-12
	9777	Which placebo to cure depression? A thought-provoking network meta-analysis Enthalten in BMC medicine Bd. 11, 25.10.2013, Nr. 1, date:12.2013: 1-10
	9778	Which treatment for low back pain? A factorial randomised controlled trial comparing intravenous analgesics with oral analgesics in the emergency department and a centrally acting muscle relaxant with placebo over three days [ISRCTN09719705] Enthalten in BMC emergency medicine Bd. 1, 9.11.2001, Nr. 1, date:12.2001: 1-7
	9779	Whoever is Free from “Placebo Sensitivity”, Cast the First Stone! Enthalten in The American journal of gastroenterology Bd. 113, 3.7.2018, Nr. 8, date:8.2018: 1255
	9780	Why are CGRP monoclonal antibodies not yet the first line treatment in migraine prevention? Enthalten in Arquivos de neuro-psiquiatria Bd. 80, 2022, Nr. S 05, 05: 214-217